Unravelling adenosine's effects on stroke.
Fricker
J
J
D000241:Adenosine / Q000378:metabolism*; D000818:Animals; D002545:Brain Ischemia / Q000188:drug therapy / Q000378:metabolism; D017353:Gene Deletion; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D019636:Neurodegenerative Diseases / Q000188:drug therapy; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use; D010641:Phenotype; D058915:Purinergic P1 Receptor Antagonists; D043705:Receptor, Adenosine A2A; D018047:Receptors, Purinergic P1 / Q000235:genetics / Q000378:metabolism*; D020521:Stroke / Q000188:drug therapy / Q000378:metabolism*
D018696:Neuroprotective Agents; D058915:Purinergic P1 Receptor Antagonists; D043705:Receptor, Adenosine A2A; D018047:Receptors, Purinergic P1; D018698:Glutamic Acid; D000241:Adenosine